Compare VNCE & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNCE | CNXU |
|---|---|---|
| Founded | 2002 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.5M | 111.7M |
| IPO Year | 2013 | 2025 |
| Metric | VNCE | CNXU |
|---|---|---|
| Price | $10.10 | $3.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 548.9K | 163.1K |
| Earning Date | 09-10-2026 | 02-03-2027 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 132.45 | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | ★ $300,007,000.00 | N/A |
| Revenue This Year | $12.72 | N/A |
| Revenue Next Year | $17.67 | N/A |
| P/E Ratio | $15.46 | ★ N/A |
| Revenue Growth | ★ 2.23 | N/A |
| 52 Week Low | $1.95 | $3.60 |
| 52 Week High | $12.99 | $13.66 |
| Indicator | VNCE | CNXU |
|---|---|---|
| Relative Strength Index (RSI) | 58.17 | 29.51 |
| Support Level | $5.16 | N/A |
| Resistance Level | N/A | $5.47 |
| Average True Range (ATR) | 1.35 | 0.41 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 59.74 | 2.97 |
Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale and Vince Direct-to-consumer. It operates its e-commerce business through its website. Maximum of its revenue generated from Vince Wholesale segment.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.